Immunogen, Inc. (IMGN) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.25 million versus the consensus estimate of $4.24 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Core Molding Technologies, Inc. (CMT) Misses Q3 EPS by 3c
- Sysco Corp. (SYY) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
